Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Protection of pancreatic &bgr;-cells during islet isolation and assessment of islet viability and candidate diabetes drugs after islet isolation

Protection of pancreatic &bgr;-cells during islet isolation and assessment of islet viability and candidate diabetes drugs after islet isolation

US Patent 6361995 · Granted Mar 26, 2002

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods targeting interleukin-192025
Anti-ANGPTL 3/8 complex antibodies and methods of using the same2024
Compounds and methods targeting interleukin-192023
Polynucleotides for preparing ANGPTL 3/8 complexes2022
Anti-ANGPTL ⅜ complex antibodies and methods of using the same2022
ANGPTL3/8 complexes and methods of using the same2021
Method of inhibiting pancreatic &bgr;-cell p135 O-glycosylation2003
Method of inhibiting pancreatic &bgr;-cell p135 O-glycosylation2003